| Laura P Smith, MD | |
|
4100 Olympia Cir Ste 201, Charlottesville, VA 22911-3620 | |
| (434) 220-6620 | |
| (434) 220-6621 |
| Full Name | Laura P Smith |
|---|---|
| Gender | Female |
| Speciality | Specialist |
| Location | 4100 Olympia Cir Ste 201, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386863421 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 0101246834 (Virginia) | Secondary |
| 174400000X | Specialist | 0101246834 (Virginia) | Primary |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
The new splint can reduce the need for large external support structures to fixate the hip following hip surgery. The secret behind the fast development is collaboration between a research scientist, an enterprise and a full-time student using this case for her bachelor project.
Despite progress in raising the vaccination rates in the world's poorest countries, some countries, including the Democratic Republic of Congo, Ethiopia, India, Indonesia and Nigeria continue to have vaccination rates "below 50% in certain regions, compared with the 80% or more needed to achieve a low risk of the disease spreading," Douglas Holt, Oxford University professor of marketing, and Jacob McKnight, also of Oxford University, write in a Livemint.com analysis piece.
Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that it has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital. Proceeds from the financing will be used to advance current clinical programs, strengthen platform capabilities and further expand the team.
An Illinois court rules on pharmacies' right to sell - or not - the 'morning after pill' while New York City expands the pill's availability.
Today, the U.S. Food and Drug Administration, in partnership with the Centers for Disease Control and Prevention, released new data from the 2020 National Youth Tobacco Survey, which show 1.8 million fewer U.S. youth are currently using e-cigarettes compared to 2019.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura P Smith, MD 595 Martha Jefferson Dr Ste 390, Charlottesville, VA 22911-4669 Ph: (434) 654-8524 | Laura P Smith, MD 4100 Olympia Cir Ste 201, Charlottesville, VA 22911-3620 Ph: (434) 220-6620 |
News Archive
The new splint can reduce the need for large external support structures to fixate the hip following hip surgery. The secret behind the fast development is collaboration between a research scientist, an enterprise and a full-time student using this case for her bachelor project.
Despite progress in raising the vaccination rates in the world's poorest countries, some countries, including the Democratic Republic of Congo, Ethiopia, India, Indonesia and Nigeria continue to have vaccination rates "below 50% in certain regions, compared with the 80% or more needed to achieve a low risk of the disease spreading," Douglas Holt, Oxford University professor of marketing, and Jacob McKnight, also of Oxford University, write in a Livemint.com analysis piece.
Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that it has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital. Proceeds from the financing will be used to advance current clinical programs, strengthen platform capabilities and further expand the team.
An Illinois court rules on pharmacies' right to sell - or not - the 'morning after pill' while New York City expands the pill's availability.
Today, the U.S. Food and Drug Administration, in partnership with the Centers for Disease Control and Prevention, released new data from the 2020 National Youth Tobacco Survey, which show 1.8 million fewer U.S. youth are currently using e-cigarettes compared to 2019.
› Verified 1 days ago